Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of YM155 in Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Subjects
This study has been terminated.
( Futility boundary at interim analysis not met )
Study NCT00498914   Information provided by Astellas Pharma Inc
First Received: July 10, 2007   Last Updated: May 8, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lymphoma, Large-Cell, Diffuse
Lymphoma, B-Cell Refractory
Additional conditions recognized in this trial
Lymphoma
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoma, Non-Hodgkin
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
YM155
Sponsors listed in this trial
Astellas Pharma Inc


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services